Gaois

Cóip statach de shonraí a easpórtáiltear ó IATE ó am go chéile atá sa chnuasach seo. Níor cheart glacadh leis gurb ionann i gcónaí an t-eolas a thugtar faoi iontráil anseo agus a bhfuil sa leagan reatha den iontráil ar IATE. Is féidir an leagan reatha sin a cheadú ach cliceáil ar an nasc atá ar thaobh na láimhe deise ag barr gach iontrála. Breis eolais »

1 toradh

  1. SOCIAL QUESTIONS|health|pharmaceutical industry

    #572324

    IATE #3500863
    an Coiste Cógas-Aireachais um Measúnú Rioscaí Tagairt Rialachán (AE) 658/2014 maidir le táillí is iníoctha leis an nGníomhaireacht Leigheasra Eorpach chun gníomhaíochtaí cógas-aireachais a dhéanamh i ndáil le táirgí íocshláinte lena n-úsáid ag an duine, CELEX:32014R0658/GA Faomhadh an téarma seo mar chuid de Thionscadal Lex
    ga
    Ausschuss für Risikobewertung im Bereich der Pharmakovigilanz | Beratender Ausschuss für Risikobewertung im Bereich der Pharmakovigilanz
    de
    Pharmacovigilance Risk Assessment Committee | PRAAC | Pharmacovigilance Risk Assessment Advisory Committee | PRAC
    en
    Sainmhíniú committee, forming part of the European Medicines Agency, which is responsible for providing recommendations to the Committee for Medicinal Products for Human Use and the coordination group (set up by Article 27 of Directive 2001/83/EC on the Community code relating to medicinal products for human use) on any question relating to pharmacovigilance activities in respect of medicinal products for human use and on risk management systems and responsible for monitoring the effectiveness of those risk management systems Tagairt COM-EN, based on: Article 56(1)(aa) of Regulation (EC) No 726/2004 laying down Community procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (consolidated text: CELEX:02004R0726-20130605/EN ), inserted by Regulation (EU) No 1235/2010, CELEX:32010R1235/EN
    comité pour l’évaluation des risques en matière de pharmacovigilance | comité consultatif pour l’évaluation des risques en matière de pharmacovigilance
    fr
    Sainmhíniú comité chargé de présenter des recommandations au comité des médicaments à usage humain [IATE:843393] et au groupe de coordination sur toute question relative aux activités de pharmacovigilance Tagairt Règlement (UE) nº 1235/10 modifiant, en ce qui concerne la pharmacovigilance des médicaments à usage humain, le règlement (CE) n ° 726/2004 (...), et le règlement (CE) n ° 1394/2007 (...), CELEX:32010R1235/FR
    PRAC
    mul